1. Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression
   HAI ZHANG et al, 2014, International Journal of Oncology CrossRef
2. Prostaglandin E2 receptor EP1 expression in vulvar cancer
   Anna Buchholz et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
3. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells
   XIAOMING BAI et al, 2014, Molecular Medicine Reports CrossRef
4. Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway
   Xiaoming Bai et al, 2014, Scientific Reports CrossRef
5. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy
   Qiushi Wang et al, 2022, Cancer Research CrossRef
6. Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
   Ana Santiso et al, 2024, Pharmacological Reviews CrossRef
7. Prostaglandins regulate invasive, collective border cell migration
   Emily F. Fox et al, 2020, Molecular Biology of the Cell CrossRef
8. Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma
   Chao Chen et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
9. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling
   SHAOSHAN HAN et al, 2014, Oncology Reports CrossRef
10. Cyclooxygenase-2 induced β1-integrin expression in NSCLC and promoted cell invasion via the EP1/MAPK/E2F-1/FoxC2 signal pathway
    Jinshun Pan et al, 2016, Scientific Reports CrossRef
11. The far-upstream element-binding protein 2 is correlated with proliferation and doxorubicin resistance in human breast cancer cell lines
    Ying-Ying Wang et al, 2016, Tumor Biology CrossRef
12. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
    Yi Yu et al, 2014, Journal of Experimental & Clinical Cancer Research CrossRef
13. Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival
    Hao-Jie Yang et al, 2016, World Journal of Gastroenterology CrossRef
14. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway
    Song Xu et al, 2018, Molecular Medicine Reports CrossRef
15. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway
    SHUKAI XIA et al, 2014, Oncology Reports CrossRef
16. Inhibition of PKC/MEK pathway suppresses β1-integrin and mitigates breast cancer cells proliferation
    Nahla E. EL-Ashmawy et al, 2021, Toxicology Reports CrossRef
17. EP1 receptor: Devil in emperors coat
    Umar Mushtaq, 2023, Journal of Cellular Biochemistry CrossRef
18. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment
    Donna M. Sosnoski et al, 2015, Clinical & Experimental Metastasis CrossRef
19. Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
    G O'Callaghan et al, 2015, British Journal of Pharmacology CrossRef
20. Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer
    M T M van Jaarsveld et al, 2016, Oncogene CrossRef
21. Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK
    YAN-JIAN HU et al, 2014, International Journal of Molecular Medicine CrossRef